Nareg Sagherian | Executive Director, Investor Relations |
Jerry Durso | President and CEO |
Andrew Saik | Chief Financial Officer |
Linda Richardson | Chief Commercial Officer |
Michelle Berrey | President, Research & Development and Chief Medical Officer |
Yasmeen Rahimi | Piper Sandler |
Mayank Mamtani | B. Riley Securities |
Ed Arce | H.C. Wainwright |
Brian Abrahams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Jon Wolleben | JMP Securities |
Thomas Smith | Leerink Partners |
Eliana Merle | UBS |
Ryan Deschner | Raymond James |
Ritu Baral | Cowen |
Matthew Dellatorre | Goldman Sachs |
Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]